Результаты исследований: Вклад в журнал › Статья › Рецензирование
Результаты исследований: Вклад в журнал › Статья › Рецензирование
}
TY - JOUR
T1 - Comparative study on application of 177Lu-labeled rituximab, tetulomab, cetuximab and huA33 monoclonal antibodies to targeted radionuclide therapy
AU - Zakaly, Hesham M.H.
AU - Mostafa, Mostafa Y.A.
AU - Dzholumbetov, Sergey
AU - Issa, Shams A.M.
AU - Tekin, H. O.
AU - Erdemir, R. Uslu
AU - Zhukovsky, M.
PY - 2020/11
Y1 - 2020/11
KW - BIODISTRIBUTION
KW - NEUROENDOCRINE TUMORS
KW - cetuximab
KW - huA33
KW - lutetium-177
KW - monoclonal antibody
KW - rituximab
KW - targeted radionuclide therapy
KW - tetulomab
UR - http://www.scopus.com/inward/record.url?scp=85098270596&partnerID=8YFLogxK
UR - https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=tsmetrics&SrcApp=tsm_test&DestApp=WOS_CPL&DestLinkType=FullRecord&KeyUT=000600804600001
U2 - 10.1088/2057-1976/abd307
DO - 10.1088/2057-1976/abd307
M3 - Article
AN - SCOPUS:85098270596
VL - 7
JO - Biomedical Physics and Engineering Express
JF - Biomedical Physics and Engineering Express
SN - 2057-1976
IS - 1
M1 - 015015
ER -
ID: 20406920